Editorial: Progress and challenges in computational structure-based design and development of biologic drugs

被引:2
|
作者
Sulea, Traian [1 ]
Kumar, Sandeep [2 ]
Kuroda, Daisuke [3 ]
机构
[1] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada
[2] Moderna Therapeut, Computat Prot Design & Modeling, Computat Sci, Cambridge, MA 02139 USA
[3] Natl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, Tokyo, Japan
关键词
binding affinity; specificity; therapeutic antibody; developability; in silico method; molecular modeling; molecular simulations; machine learning; PREDICTION;
D O I
10.3389/fmolb.2024.1360267
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Structure-based computational design of antibody mimetics: challenges and perspectives
    Chaves, Elton J. F.
    Coelho, Danilo F.
    Cruz, Carlos H. B.
    Moreira, Emerson G.
    Simoes, Julio C. M.
    Nascimento-Filho, Manasses J.
    Lins, Roberto D.
    FEBS OPEN BIO, 2025, 15 (02): : 223 - 235
  • [2] Progress in Structure-Based Design of EGFR Inhibitors
    Mitrasinovic, Petar M.
    CURRENT DRUG TARGETS, 2013, 14 (07) : 817 - 829
  • [3] Antibody humanization by structure-based computational protein design
    Choi, Yoonjoo
    Hua, Casey
    Sentman, Charles L.
    Ackerman, Margaret E.
    Bailey-Kellogg, Chris
    MABS, 2015, 7 (06) : 1045 - 1057
  • [4] Computational support of structure-based targeted covalent inhibitor design
    Abel, Robert
    Friesner, Richard
    DESIGN OF COVALENT-BASED INHIBITORS, 2021, 56 : 229 - 242
  • [5] Computational structure-based drug design: Predicting target flexibility
    Iglesias, Jelisa
    Saen-oon, Suwipa
    Soliva, Robert
    Guallar, Victor
    WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2018, 8 (05)
  • [6] Novel computational pipelines in antiviral structure-based drug design (Review)
    Diakou, Io
    Papakonstantinou, Eleni
    Papageorgiou, Louis
    Pierouli, Katerina
    Dragoumani, Konstantina
    Spandidos, Demetrios A.
    Bacopoulou, Flora
    Chrousos, George P.
    Eliopoulos, Elias
    Vlachakis, Dimitrios
    BIOMEDICAL REPORTS, 2022, 17 (06)
  • [7] Structure-based Drugs Design Studies on Spleen Tyrosine Kinase Inhibitors
    Assis, Leticia Cristina
    Garcia, Leticia Santos
    Mancini, Daiana Teixeira
    Assis, Tamiris Maria
    Silva, Daniela Rodrigues
    Cardoso, Giovanna Gajo
    de Castro, Alexandre Alves
    Ramalho, Teodorico Castro
    Ferreira da Cunha, Elaine Fontes
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (09) : 845 - 858
  • [8] Selective and Effective: Current Progress in Computational Structure-Based Drug Discovery of Targeted Covalent Inhibitors
    Bianco, Giulia
    Goodsell, David S.
    Forli, Stefano
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (12) : 1038 - 1049
  • [9] Computational structure-based redesign of enzyme activity
    Chen, Cheng-Yu
    Georgiev, Ivelin
    Anderson, Amy C.
    Donald, Bruce R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) : 3764 - 3769
  • [10] Structure-based, rational design of T cell receptors
    Zoete, V.
    Irving, M.
    Ferber, M.
    Cuendet, M. A.
    Michielin, O.
    FRONTIERS IN IMMUNOLOGY, 2013, 4